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We have described (1) a biologically active antigen-specific Ly-1-; 2  + T cell product 
that has the capacity to suppress the ability of Ly-2 cell-depleted spleen cells to make 
primary responses in Mishell-Dutton cultures. It has been presumed that this material, 
referred  to  as  "Ly-2 suppressor  factor from T  cells  (TsF), ''1  is  a  direct  suppressor 
molecule because (a) it requires no other cells with a suppressor cell phenotype in the 
culture to work, and (b) its suppressive effect can be seen when the assay cultures are 
harvested  early  during  the  course  of an  in  vitro  immune  response.  Inducers  of 
suppression require a longer latent period before their suppressive activity is expressed 
(2). An interesting feature of this Ly-2 TsF is that it does not express any I-J or other 
major histocompatibility complex (MHC)-controlled specificities that can be detected 
with the use of a large battery of antisera. Nonetheless, the biological activity of the 
molecule is restricted by the MHC polymorphisms expressed by the producer:acceptor 
cell partners. 
This latter finding might be interpreted to indicate that the Ly-2 TsF must react 
with an MHC-controlled gene product in the acceptor cell population to express its 
biological activity. We tested this proposition by treating normal Ly-1 T cells with an 
anti-I-J serum before adding these cells to T  cell-depleted spleen cells (B cells)  and 
determining whether the anti-I-J  treatment of the  normal  Ly-1  cells had affected 
either (a)  the ability of the Ly-1 cells to help the T  cell-depleted spleen cells or (b) 
changed the ability of the Ly-2 TsF to suppress the cultures. 
We found that the anti-I-J treatment of the Ly-1 T cells did not affect their ability 
to help T cell-depleted spleen cell cultures but completely abrogated the ability of the 
Ly-2 TsF to suppress  the helper activity in such cultures. We also found that  the 
cultures that lack I-J  + Ly-1 cells can be suppressed by the Ly-2 TsF when the eluate 
from an anti-I-J immunoabsorbent through which an I-J  + Ly-1 T  cell suppressor- 
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inducer factor had  been  passed  is added back to the cultures.  The  eluted  material 
neither binds antigen nor must it come from Ly-1 cells that have the relevant antigen 
specificity (3). Interestingly, the Ly-1 cell that makes the I-J  + material used to return 
the suppressive capacity to the Ly-2 TsF must match the I-J haplotype of the cell that 
makes  the  Ly-2 TsF  and  also  must  share  an  Igh-V-linked polymorphism  with  the 
Ly-2 TsF target cell but not the Ly-2-TsF itself. 
These results indicate that two separate macromolecules are required for effecting 
suppression as well as for inducing suppression (3). They can also give us some insight 
into the biological roles of the two macromolecules involved in effecting the suppres- 
sion. 
Materials  and  Methods 
Mice.  C57BL/6,  BALB/c, AKR B10.Br,  C57BL/10J,  and  CB6F1  mice, 6-10  wk of age, 
were obtained from The Jackson Laboratory, Bar Harbor, ME. BALB/B and BALB/K mice 
were from the Yale University School of Medicine. BALB/c nu/nu mice were maintained at the 
National Institutes of Health animal facility. Preparation of bone marrow chimeras and thymus 
grafted nu/nu  mice  is  detailed elsewhere,  and  they were supplied to  us  by  Alfred Singer, 
National Cancer Institute, National Institutes of Health, Bethesda, MD. 
Antisera.  Monoclonal  anti-Ly sera  were  generously supplied  by  F.-W.  Shen,  Memorial 
Sloan-Kettering Cancer Center, New York. Monoclonal anti-Thy-1 reagents were generousl~ 
provided by Dr. Jonathan  Sprent,  University of Pennsylvania,  Philadelphia, PA.  Anti-I-J 
serum was prepared by hyperimmunizing B 10.A (5R) recipients with a mixture of B 10.A (3R) 
spleen and lymph node cells (antiserum ASM-20)  (we thank D. Murphy for preparing these 
antisera).  2 Depletion of cells bearing Lyt or I-J  b markers was achieved by incubating 1 ×  107 
cells/ml of antibody appropriately diluted in balanced salt solution (BSS) (1:1,000 for anti-Ly 
monoclonal antibody, 1:5 for anti-Thy-1 monoclonal antibody hybridoma supernatant, or 1:5 
for anti-I-J serum), washing, and incubating with complement for 45 rain at 37°C  (1  ×  107 
cells/ml of rabbit serum diluted 1:10  for anti-Ly or anti-I-J antibody or 1 ×  107 cells/ml of 
guinea pig complement for anti-Thy-1 antibody). Complement used in these experiments was 
serum from animals selected for low natural cytotoxicity to mouse spleen cells. 
Antigens.  Sheep erythrocytes (SRBC) were obtained from Colorado Serum Company Lab- 
oratories, Denver, CO. 
Method of Cell Preparation.  Spleen cells were washed in BSS and suspended in RPMI  1640 
supplemented with antibiotics, 10% fetal calf serum (FCS), 100 mM glutamine, 25 mM Hepes, 
and  5  ×  10  -s  M  2-mercaptoethanol  for  tissue  culture.  T  cells were  prepared  by  adding 
unprimed spleen cells to plastic petri dishes coated with goat anti-mouse immunoglobulin and 
harvesting  the  nonadherent  fraction(s).  B  cells  were  prepared  by  treating  the  cells with 
monoclonal anti-Thy- 1 and complement. 
Preparation of Lyt 1 +-derived Suppressor-Inducer (Ly-1 TsiF) and the Lyt 2+-derived Suppressor-Effector 
(Ly-2 TsF) Materials.  Preparation of Ly-1 TsiF and Ly-2 has been previously described (1, 2). 
Briefly, a suspension of spleen cells from mice hyperimmunized with SRBC was treated with 
anti-Lyt-2 (for Ly- 1 TsiF) or anti-Lyt- 1 (for Ly-2 TsF) and rabbit complement and subsequently 
cultivated in vitro for 48 h  in RPMI  1640 plus  10% FCS at a  concentration of 107 cells/ml. 
After 48 h, supernatant fluids were cleared and passed through millipore filters. 
Absorption of Soluble Factors.  Absorbtion with erythrocytes was done by mixing 1 ml of culture 
supernatants  with  0.1  ml  of a  50%  suspension  of sheep  erythrocytes for  1  h  on  ice.  The 
erythrocytes were removed by centrifugation. For absorbtion with anti-I-J sera, supernatant 
fluids were passed over an anti-I-J immunoabsorbent  (ASM-20) prepared by conjugation of 
antisera to cyanogen bromide-activated Sepharose. 
Assay Cultures.  Suppressor activity of the Ly-1 TsiF or the Ly-2 TsF was determined by 
2 Antisera production was supported by a Core facility in grant Ca 29606. 
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adding these materials to cultures of unprimed spleen cells that had been treated with various 
test reagents. All cells were suspended in culture medium at a concentration of 2 ×  106 T  cells 
and 2 ×  108 B cells in 1 ml and cultured with 0.05 ml of a  1% SRBC suspension in Falcon 3008 
plates (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) in a 5% CO2, 95% air 
incubator at  37°C. The number of plaque-forming cells  (PFC)  was determined on day 5 by 
using the Cunningham modification of the Jerne-Nordin plaque assay, as previously described 
(4). Results are given as the mean of three individual calculations from each culture condition. 
Isolation of l-J + Molecule from Ly-I  TsiF.  Supernatants  containing Ly-1 TsiF were passed 
over the appropriate immunosorbent column made from anti-I-J antisera coupled to Sepharose 
4B. After extensive washing, the column was eluted with 0.2 M  sodium carbonate (Na2CO3), 
pH 11.0, and immediately neutralized in 0.3 M borate buffer, pH 8.3. The eluted material was 
then concentrated to original volume and dialyzed overnight against, first,  PBS, then RPMI 
1640. 
Results 
Removal of I-J + Ly-1 Cells from Assay Cultures Prevents Suppression by Ly-2 TsF (Table 
I).  Supernatants  from cultured immune Ly-2 cells had a potent suppressive activity 
when  added  to assay cultures  composed of Ly-1 T  cells and Thy-l-depleted  spleen 
cells (compare group 1 with group 2; Table I). Removal of I-J  + Ly-1 T  cells from the 
assay cultures did not significantly alter their activity in the absence of the suppressive 
Ly-2 TsF  (group 3).  However, even though the response in  the cultures  depleted of 
I-J  + Ly-1 cells showed no significant change in the absence of Ly-2 TsF, there was a 
marked difference in the response of these cultures when Ly-2 TsF was added (group 
4).  Under these conditions the Ly-2 TsF failed to manifest any suppressive  activity. 
Thus, an I-J  + Ly-1 cell in the assay culture must interact  with the Ly-2 TsF to give 
the TsF biological activity. 
Return of I-J + Material from Ly-I  Cells Allows the Ly-2  TsF to Suppress Assay Cultures 
Depleted of I-J + Ly-1 Cells  (Table II).  Appropriately immunized  Ly-1 cells release a 
suppressor-inducer  factor (Ly-1 TsiF)  (2)  that  is composed of two separable  macro- 
molecules;  one of these  macromolecules bears  an  I-J-controlled determinant  and  is 
the molecule that imparts an Igh-V-linked restriction on the factor's activity (3). We 
therefore  asked  the  question  of whether  I-J  +  material  isolated  from  an  Ly-1  TsiF 
would allow the Ly-2 TsF to manifest suppressive activity in cultures depleted of I-J  + 
Ly-1 cells. The results of such an experiment  (Table I) recapitulate the findings in the 
experiments reported in Table I  (i.e., they show that anti-I-J treatment of the Ly-1 T 
cells in the assay culture does not inhibit  helper activity but completely inhibits  the 
ability  of the  Ly-2 TsF  to effect  suppression).  The  key  finding  is  that  in  group  5, 
where it is shown that the addition of the eluate from an I-J column through which 
TABLE  I 
Removal of I-J  + Ly-I Cells  from Assay Cultures Prevents Suppression by Ly-2 TsF 
Ly-2 TsF  Percent 
Group  Cells added to cultures  added$  PFC/culture  suppression 
1  Ly- 1 T cells  -  3,000  Standard 
2  Ly-1 T cells  +  500  83 
3  I-J- Ly-1 T cells  -  2,600  Standard 
4  I-J- Ly-1 T cells  +  2,200  15 
* All cultures contained anti-Thy-l-treated  spleen cells and SRBC. 
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TABLE  II 
Return of I-J + Material Isolated from Ly-1 Cells Allows Ly-2 TsF to Suppress B6 Assay Cultures 
Depleted of l-J + Ly-I Cells 
Ly-2 TsF  Ly-1 I-J  PFC/culture  Percent suppression  Group  Cells added to cultures*  added:~  added 
1  Ly- 1 T cells  -  -  3,400  Standard 
2  Ly-I T cells  +  -  1,100  68 
3  I-J- Ly- 1 T cells  -  -  3,000  Standard 
4  I-J- Ly-1 T cells  +  -  3,000  0 
5  I-J- Ly-I T cells  +  +  1,000  67 
* See footnotes,  Table I. 
~: See footnotes, Table I. 
TABLE III 
Genetic Requirements That Allow Ly-1 I-J + Material to Assist Ly-2 TsF in Suppressing B6 Assay 
Cultures Depleted of I-J + Ly-1 Cells; I-J + Material Must Match Ly-2 TsF at H-2 and the Acceptor Cell 
at Igh-linked Polymorphisms 
Source of  I-J  + 
molecule 
Source of Ly-2 TsF 
None  B6  BALB/c  AKR  C.B20 
None  7,500*  6,500  7,000  6,200  5,900 
B6  8,000  1,600~  5,800  7,000  4,600 
BALB/c  7,500  5,600  5,700  6,600  6,800:~ 
C.B20  7,400  5,800  2,200  7,200  2,100 
BALB/B  7,100  6,400  6,000  6,700  5,800 
* (PFC/culture)  all assay cultures contained B6 Thy- 1- spleen cells and B6 I-J- Ly- 1 cells and SRBC. 
~: Important negative control for reciprocal combination. 
§ Italicized  numbers  indicate cultures  suppressed  by appropriate combination  of Ly-2 TsF and  I-J  + 
molecule. 
an  Ly-1  TsiF had been  passed, allowed the Ly-2 TsF to express its full suppressive 
potential in cultures that did not contain I-J  + Ly-1 cells. 
Genetic Requirements  That Allow Ly-l-derived I-J + Material to Interact with the Ly-2  TsF 
in Suppressing Cultures Depleted of I-J + Ly-1 Cells," the I-J + Material Must Share MHC-linked 
Polymorphisms with the Ly-2 TsF and Igh-linked Polymorphisms with the Acceptor Cell.  (Table 
III).  The fact that the Ly-2 TsF, which is H-2 restricted, needs to interact with the 
I-J  + molecule in the assay cultures to manifest its suppressive activity, suggested that 
its  H-2  restriction  might  be  anti-I-J  and  that  it  was  this  anti-I-J  specificity that 
allowed it  to  act  in  concert  with  the  I-J  +  material from  the  Ly-1  TsiF to perform 
suppression. To test this hypothesis, we took B6 spleen cells that had been depleted of 
Thy-1 + cells and added back to them B6 Ly-1 T  cells that had been treated with anti- 
I-J. To these assay cultures, we added Ly-2 TsF from four different mouse strains and 
I-J  +  molecules from  the same four strains. The  results of such  an  experiment show 
that only three of these molecular mixtures returned suppressive activity to the Ly-2 
TsF  in  the  cultures  of B6  spleen  cells  that  lacked  I-J  +  Ly-1  cells.  One  was  the 
homologous mixtures  (B6 with B6). This was simply a  repeat of the results reported 
in  Table  II.  The  more  interesting results  were  those  obtained  with  material  from 
C.B20  mice. C.B20  Ly-2 TsF could interact appropriately with C.B20  I-J  + material 
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a  suppressive unit that will work on cells that share Igh-V-linked gene products with 
the cell that  made  the I-J  +  material.  The  mapping  of the Igh-V-linked restriction  to 
the I-J  + chain's interaction with the B6 acceptor cell is substantiated  by the observa- 
tion  that  a  BALB/c  Ly-2  TsF  could  replace  the  C.B20  Ly-2  TsF  in  restoring 
suppression  but that  the reverse was not true. That  is, the C.B20 Ly-2 TsF could not 
be restored with I-J  + material from BALB/c. These results indicate that I-J is involved 
in the interaction  between  the I-J  ÷  and  I-J- macromolecules  and  forms a  molecular 
complex  that  interacts  with  the  acceptor  cell  via  an  Igh-V-linked  receptor.  In  the 
absence of an H-2 match  between the two chains and an Igh match  between the I-J  + 
chain and the acceptor cell, no suppression  occurred.  These findings and conclusions 
are consistent  with the previous report  that  the 1-J  + molecule was responsible for the 
Igh-V-linked restriction  of the Ly-1 TsiF (3). 
Genetic Requirements That Allow the Ly-l-derived  I-J + Material to Interact with the Ly-2 
TsF in Suppressing Cultures Depleted of I-J  ± Ly-1  Cells; the I-J ± Material Must Share I-J- 
linked Polymorphisms with the Ly-2  TsF and IgH-V-linked Potymorphisms with the Acceptor 
Cell.  (Summary)  (Table  IV).  The  results  of two  more  experiments  looking  at  the 
genetic requirements  for functional  reconstitution  of Ly2-TsF in cultures  that  lack I- 
J+ Ly-1  cells are presented  in Table  IV, using B6 spleen cells as assay ceils. In Table 
IV, it can be seen that in every circumstance save one (17 of 18 determinations)  where 
there  was  an  H-2  match  between  the  two  molecules  that  formed  the  suppressive 
TABLE  IV 
Genetic Requirements That Allow Ly-1 I-J  + Material to Assist Ly-2 TsF in Suppressing B6 Assay 
Cultures Depleted of I-J  + Ly-1 Cells; I-J  + Material Must Match Ly-2 TsF at 1-1-2  and the Acceptor Cell 
at Igh-linked Polymorphisms (Summa,y) 
Source of I-J  + 
molecule* 
Source of Ly-2 TsF 
B6 into  None  B6  BALB/c  AKR  C.B20  CB6Fx 
I  H  I  H  I  H  I  H  H  I  H 
None  05  0:l:  0  0  0  0  0  0  0  0  0 
B10 or B6§  0  0  +  ++  0  0  0  0  ±  ++  ++ 
BI0.Br  0  0  0  0  0  0  ++  +  ±  +  0 
BI0.A(3R)  0  0  ++  --  0  --  0  --  --  ++  -- 
B10.5A(5R)  0  0  0  --  0  --  ++  --  --  0  -- 
BALB/c  0  0  --  0  --  0  --  0  0  --  0 
C.B20  0  0  0  0  ++  +  0  0  +  0 H  ++ 
Bab.14  0  0  0  --  0  --  0  --  --  0  -- 
BALB.B  0  0  0  0  0  0  0  ±  0  0  0 
BALB.K  0  0  --  0  --  0  --  0  0  --  0 
BALB/c  nude +  CB6Fa 
T.G.  0  0  0  0  ++  +  0  0  ++  ++  ++ 
* I and II refer to separate experiments. The I-J  ÷ nonantigen-binding material from Ly-1 TsiF obtained by 
affinity chromatography over an anti-I-J immunosorbent in experiment labeled I and by absorbtion of 
Ly-1 TsiF with S  RBC in experiment labeled II. 
:[: Results are from assay cultures that contained Thy- 1- B6 spleen cells and I-J- B6 Ly- I cells and SRBC. 
Results are presented as percent suppression  of cuhure that served as positive control (3,400 PFC/culture 
in experiment 1 and 3,100 PFC/culture in experiment II). 0, <25% suppression;  ±, 25-49%  suppression; 
+, 50-74% suppression;  ++, 75-100% suppression;  --, not done. 
§ B10 mice in experiment I and B6 in experiment II. 
[I We have no explanation as to why this result  was  negative; perhaps  a  technical error was  made. We 
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complex and an Igh-V match between the I-J  + portion of that complex and the B6 
acceptor cells, suppression was manifest. In all cases where these two criteria were not 
met, no significant suppression was seen. 
Additional information found in these series of experiments is: (a) the H-2 matching 
requirement  that  helps  the  two chains  to  form an  appropriate  molecular complex 
maps to I-J as the B6 Ly-2 TsF could react with the 3R (I-J  b) and not the 5R (I-Jk), 
whereas the AKR Ly-2 TsF could react with the 5R and not the 3R;  and  (b)  these 
results also map the Igh linkage in the present studies to Igh-V (as previous studies 
had done)  (3) because the BALB/c Ly-2 TsF could work appropriately with a C.B20 
I-J  + molecule but not with a  BAB.14 I-J  + molecule (BAB.14 and C.B20 mice differ 
genetically only in a portion of 12th chromosome that is linked to Igh-V). 
An added interesting observation was made using factors from chimeric mice. We 
have previously shown  n that parental cells that differentiate in an F1 thymus graft can 
suppress  the  response  of cells  from  the  reciprocal  parent  in  the  F1  cross.  In  the 
experimental  results  presented  in  Table  IV,  we  used  an  Ly-2 TsF  from  a  CB6F1 
radiation chimera that had been repopulated with B6 bone marrow cells. Under these 
circumstances,  the  B6  Ly-2  TsF  from  the  chimeric  mice  could  interact  with  I-J  + 
material from the C.B20 and form a suppressive unit. Thus, the B6-derived Ly-2 TsF 
in  the  chimera  had  "learned"  to  see  the  MHC-linked  polymorphism on  the  I-J  + 
C.B20 molecule and could act to suppress B6 cells because the C.B20 I-J  + molecule 
matched the acceptor cell at Igh-V. 
In addition, the Ly-2 TsF from the B6 into CB6 F1 chimera could interact with an 
I-J  + molecule derived from a  BALB/c nude mouse that had been engrafted with a 
CB6F1 thymus. Previous studies (6) have shown that the molecules of the latter type 
of chimera express the I-J  d polymorphisms, so it can be concluded  that the B6 cells 
have learned in the F1 chimera to see the I-Ja-linked polymorphisms on the Ly-1 TsiF 
from BALB/c nude mice with CB6F1 thymus grafts, and the I-J  + molecule from these 
latter chimeras have learned  to  interact  with  the  Igh-V-linked receptor on  the  B6 
acceptor cell. Note: the B6 Ly2 TsF could not form an active molecular complex with 
the  I-J  +  material  from  the  BALB/c  nude  with  the  F1  thymus  graft,  whereas  the 
BALB/c Ly-2 TsF could. Thus, it seems quite clear that the Ly-2 TsF must combine 
with  an  I-J  +  molecule  to  achieve  its  biological  activity  and  that  there  are  two 
restrictions  imposed upon  its functional  interaction  with  that  molecule:  (a)  it must 
recognize  an  I-J-controlled  polymorphism on  the  molecule  itself,  and  (b)  the  I-J  + 
molecule with which  it interacts  must recognize an Igh-V-linked polymorphism on 
the acceptor cell. 
Discussion 
We previously described (1) a product found in supernatants of immunized Ly-2 T 
cells  (Ly-2 TsF)  that is antigen specific and acts as a  direct suppressor of Ly-1 cells 
when the Ly-1 cells express the same H-2 polymorphisms as the cells that have made 
the Ly-2 TsF. We also previously described a suppressor-inducer molecule (Ly-1 TsiF) 
that can induce Ly-2 cells to express suppressor activity when the Ly-2 cells share Igh- 
V-linked polymorphisms with  the cells that  made the  Ly-1  TsiF  (2)  (these  genetic 
restrictions can be overcome in parent into F1 chimeras)  (6).  In the case of the Ly-1 
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macromolecules, one of which sees antigen and the other of which expresses I-J and 
does not see antigen. The Igh-V-linked restriction maps to this I-J  + molecule (3). 
In the present series of experiments, we attempted to determine the significance of 
the genetic restrictions described above. We learned that (a) the H-2 restriction of the 
Ly-2 TsF stems from its need to interact with an I-J  + molecule and, to interact with 
that  molecule, it must come from mice that share I-J polymorphisms with the I-J  + 
molecule;  and  (b)  for this  molecular complex to  influence  the  target  cell,  the  I-J  + 
molecule with which the Ly-2 TsF interacts must share genes linked  to Igh-V with 
the acceptor cell.  Therefore,  the  H-2 restriction  in  these conditions  is  not  one that 
prevents the Ly-2 TsF from interacting with its acceptor cell, but rather it inhibits its 
interaction with another molecule that interacts with the receptor for the molecular 
complex on the acceptor cell. The second molecule's interaction with the acceptor cell 
is restricted by Igh-V polymorphisms and thus is likely to be a  VH anti-VH type of 
reaction. 
Thus, both the Ly-2 TsF and the Ly-1 TsiF, previously reported  (3), require two 
separate macromolecules for biological function  to be seen  (a similar situation  has 
been reported with another suppressor factor under study in our laboratory, which 
acts to inhibit the activity of immune Ly- 1 cells that transfer contact hypersensitivity) 
(5). Taniguchi et al. (6) and Taussig and Holliman (7) also found that antigen-specific 
TsF are composed of at least two separate macromolecules. 
From  these  data,  a  general  working  model  by which  biologically active T  cell- 
derived factors function can be put forth. A specific model for the mechanism of the 
Ly-2 TsF we described is illustrated in Fig.  1. We tentatively assigned the functional 
information to the molecule that  is antigen  specific. There are two reasons for this 
assignment.  (a)  When  the I-J  + material that  we used to form molecular complexes 
with  the  Ly-2 TsF is mixed together with  an  antigen-binding  chain  from an  Ly-1 
TsiF, the functional activity of the molecular complex changes  (2).  In this situation, 
the  molecular complex does not  have the  ability to directly suppress T  or B  cells. 
Rather,  it  acts  as  a  suppressor-inducer  factor,  and  thus  it  will  not  suppress  Ly-2- 
depleted spleen cell cultures. Thus, if the I-J  + molecule used by the antigen-binding 
chains of the Ly-1 TsiF and the Ly-2 TsF is the same and the two molecular complexes 
have different activities, it follows that the activity, per se, is inherent in the antigen- 
binding chain.  Although  we have no direct  proof that  it  is  the same I-J  + molecule 
that  interacts  with  both  the  Ly-1-  and  Ly-2-derived  antigen-specific  functional 
molecules, there is no reason to suspect that they are different. Most importantly, in 
both  cases,  the  I-J  +  molecules  impart  an  Igh-V-linked  restriction  for  functional 
activity that suggests that if they are not the same, they are quite similar.  (b)  Fresno 
and his colleagues (8, 9) have shown that functional activity is in the antigen-binding 
chain of a clonal T  suppressor factor. The functional signal is in the C  terminal piece 
and is not part of the antigen-recognizing mechanisms. 
Based on this evidence for assigning biological activity to the antigen-binding chain 
and a lack of biological activity in the I-J  + chain, we tentatively assign a "schlepper" 
function  to  this  latter  chain.  The  evidence  suggests  that  the  I-J  +  chain  brings 
(schlepps)  the  molecule with  biological activity to  the appropriate receptor on  the 
target cell. The interaction between the I-J  + chain and the molecule on the acceptor 
cell is Igh-V linked. The I-J portion of the schlepper chain appears to be the "hook- 368  INTERACTIONS  FOR  Ly-2  SUPPRESSOR  CELL  ACTIVITY 
MOLECULE  I  MOLECULE  2 
(Schlepper  Chain)  (Functional  Chain) 
Anti-self 
(Igh-V  Linked) 
l-d  at  i_  ~ 
Informational 
Signal 
Anti-nominal 
r-  "--1  Antigen 
~__~  J  \  (SRBC) 
/ ~"nominol" 
~  antigen 
Igh-V Linked-~,~ ~'=~----~,  ,  V  .  . 
(Receptor for  ~  ~  /  ~Anh-anhgen 
Schlepper Chain) ~  /"  ~  (Receptor  for 
Functional Chain) 
Ftc.  1.  Composition and functional makeup of an antigen-specific T  suppressor factor. Molecule 
1  (schlepper chain):  the Igh-V-linked moiety (anti-Igh-V?)  focuses the  functional  chain  on  the 
appropriate cell surface receptor that  must also be Igh-V linked;  I-J  is  the receptor for anti-I-J 
specificity on  the  functional  chain.  Molecule  2  (functional  chain):  the  anti-nominal  antigen 
recognition unit brings the chain to the acceptor cell that recognizes the same antigen specificity; 
the anti-I-J connects to the schlepper chain; and the suppressor signal inhibits the helper activity of 
target cell. 
up" site that joins the schlepper chain  to the functional  antigen-specific  chain.  This 
places an 1-t-2 restriction  on the interaction  of the two chains. 
The functional  chain  recognizes "nominal"  antigen  (SRBC  in these studies).  As a 
consequence,  it will only suppress cells that see the same nominal antigen,  indicating 
that a  second interaction  site between the molecular complex and the acceptor cell is 
required  for functional  activity, and this interaction  is most  likely brought  about  by 
an antigen  bridge. The antigen-specific molecule also must carry an anti-I-a  r  (linked) 
specificity  for it  to  hook  up  to  the  I-J piece  of the  schlepper  chain.  Lastly,  for the 
reasons  listed  above,  somewhere  in  the  C  terminal  portion  of the  antigen-binding 
chain is the biologically active information  signal. 
The  question  of whether  the  situation  we  described  is unique  for the  suppressor 
molecule(s)  we described, or whether  it can act as a  general model for other antigen- 
specific T  cell  informational  molecules,  must  be  addressed.  With  a  very important 
caveat,  we think  that  a  generalization  is possible  for two  reasons:  (a)  with  three  of 
three different  suppressor  molecules that we analyzed,  two separate macromolecules 
are required  for the  deliverance  of a  biologically active signal  (3,  5).  Other workers 
(6,  7)  also  report  requirements  for  two  separate  chains  to  achieve  antigen-specific 
biological activity;  (b) the similarity between the mechanism  by which  the factor we 
described works and the way diptheria and other toxins work (1(3) indicates to us that 
the mechanism of action is an example of a  biological generalization.  In the diptheria 
model  there  are  two  chains,  as  there  are  in  our  model.  One  of these  chains  (the  B PATRICK FLOOD, KATSUMI YAMAUCHI, AND RICHARD  K. GERSHON  369 
chain)  acts as a  schlepper molecule in that it brings the A  chain to the appropriate 
receptor  site  on  the  target  cell.  Without  this  focusing  event,  the  A  chain,  which 
contains  the  information  signal,  cannot  enter the cell.  In  the case of the  diptheria 
toxin, the schlepper chain is linked to the functional unit by a disulfide bond; in the 
system we described, the linkage appears to be an I-J anti-I-J immune-like interaction, 
but  it  is possible that  the I-J anti-I-J reaction is simply helping the formation of a 
disulfide linkage. In any case, the mechanism by which the two chains link up to one 
another is not the important issue, as there might be more than one mechanism by 
which this could happen. There is evidence in some studies on T  cell molecules that 
there might be disulfide bonding of the two chains also (8). The important generali- 
zation we wish to make is of a  two chain model where one chain acts as a  schlepper 
molecule to focus the functional molecule on the appropriate cell receptor so that it 
may enter the cell and perform its function somewhere in the cytoplasmic or nuclear 
portion of the acceptor cell.  (The caveat mentioned above is that we do not propose 
that all immunological schlepper chains use the same gene products to perform their 
functions as the one we described herein.) 
The model we propose is somewhat more sophisticated than the diptheria model. 
This is because of the antigen specificity that is imparted in our system by an antigen- 
specific receptor on  the  informational  molecule. Thus,  it could  be said  that  the  T 
suppressor informational  molecules are analogous to diptheria  toxin except  that  in 
the immune situation there is a dual recognition. 
A  number of very important  questions  have been  brought  up  by this work,  for 
which we have no firm answers as yet, so rather than discussing alternatives, we will 
just list the questions raised.  (a)  How does a  product of the  17th chromosome (e.g., 
I-J) get onto the schlepper chain that is likely to be a product of the 12th chromosome 
(Igh) for two reasons:  (i)  it has an Igh-V-linked specificity and this specificity is not 
H-2 linked, indicating that it is separate from the 17th chromosome; and (ii)  in other 
studies,  we  raised  an  antiserum  that  reacts  with  this  schlepper  chain  and,  using 
somatic cell hybrids to absorb the antisera,  have been able to show that  this chain 
contains determinants that are structural gene products of the 12th chromosome (11). 
(b)  Where  is  the  gene(s)  that  imparts anti-I-J activity to the antigen-specific  infor- 
mational  chain  encoded,  and  what  is  its  relationship  to  the  anti-nominal  antigen 
specificity of that chain? Are the two recognition units (one for nominal antigen and 
the one for I-J) on different domains of a single molecule, and, if so, how do they get 
there? Clearly, this molecule can see antigen quite well, and its ability to see antigen 
is in no way dependent upon its anti-MHC specificity. 
These  important,  as yet unanswered,  questions  are presently  being  investigated. 
However, at the present time, we would like to put forth the notion that all antigen- 
specific T  cell informational molecules require an interaction between two separate 
molecules  (at  least),  one a  schlepper molecule and  one a  functional  molecule,  and 
that  the molecular complex has a  dual recognition.  The schlepper chain sees a  cell 
surface receptor  ("self" in immunological parlance)  necessary for focusing the func- 
tional molecule. (In these studies we have reported that the receptor is Igh-V linked 
or encoded  but, as stressed,  need  not  be in other circumstances.  It is quite  possible 
that I-J  + T  cell informational  molecules that have schlepper chains  that  impart an 
H-2  restriction  interact  with  different  cell  surface  receptor  molecules,  most  likely 
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The second important point  is that  the molecule that  is being schlepped has an 
antigen-specific receptor on  it,  and,  when  that  receptor is  present,  the  schlepped 
molecule will only work on cells with which it can form an antigen bridge (perhaps 
if the antigen-specific portion of the molecule were to be cleaved by an appropriate 
protease, the molecular complex would then become antigen nonspecific but would 
still function in the same way) (8, 9). 
To sum up, we should return  to the title of this manuscript.  The three focusing 
events required to deliver the biologically active signal are (a) an I-J anti-I-J hook up 
of a schlepper molecule and a functional molecule; (b) an Igh-V-linked (anti-Igh/V?) 
hook up of the molecular complex with a  target cell's surface receptor; and  (c)  an 
antigen bridge that  focuses the  informational molecule on the target cell with the 
appropriate specificity for nominal antigen. 
Summary 
We described a  T  suppressor factor made by an I-J- Ly-2 T  cell (Ly-2 TsF)  that 
expresses biological activity only when its acceptor cell shares H-2-1inked polymorphic 
genes  with  the  cells  that  made  the  Ly-2  TsF  (or  when  the  producer  cell  had 
differentiated in a  thymic environment where the gene products of the acceptor cell 
were expressed). The Ly-2 TsF requires the presence of I-J  + Ly-1 cells in the assay 
culture to express its suppressive activity, although removal of the I-J  + Ly-1 cells from 
the assay cultures does not affect the ability of those cultures to respond to antigen in 
the absence of the Ly-2 TsF. We have been able to replace the I-J  + Ly-1 cells in the 
assay cultures with an I-J+-soluble factor derived from them. This I-J  + molecule not 
only fails to bind antigen but  is also antigen nonspecific in that  it can come from 
Ly-1 cells making factors of irrelevant specificities. For the I-J  + molecule to replace 
the  activity of the  I-J  +  Ly-1  cell in  the  assay population,  in  restoring suppressive 
function in cultures depleted of I-J  + Ly-1 cells, it must share genetic polymorphisms 
linked to the I-J subregion with the Ly-2 TsF and genetic polymorphisms linked to 
Igh-V with the target cell. 
These results indicate that an I-J  + antigen-nonspecific molecule combines with an 
antigen-specific Ly-2 TsF  via  an  I-J-  anti-I-J  "type" of interaction.  The resultant 
molecular complex is  focused on  a  cell surface receptor of the  acceptor cell.  This 
focusing event is controlled by the antigen-nonspecific I-J  + molecule, and the precise 
interaction  with  the  receptor  on  the  acceptor  cell  is  controlled  by  Igh-V-linked 
polymorphic gene products. The antigenic specificity of the interaction is controlled 
by a receptor for antigen on the I-J- component of the complex. 
Thus, three focusing events are required for Ly-2 TsF to express biologic activity: 
(a)  the Ly-2 TsF must  be focused on an acceptor cell that  has  the same antigenic 
specificity (most likely via an antigen bridge); (b) it must also be focused onto an I-J  + 
antigen-nonspecific molecule that we refer to as a  "schlepper" molecule (most likely 
via an I-J anti-I-J bridge); and  (c) the schlepper molecule must focus the molecular 
complex on an Igh-V-controlled receptor on the antigen-specific target cell. 
Received  for publication 20 April 1982. 
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